发明名称 ADMINISTRACAO IONTOFORETICA DE ROTIGOTINA PARA O TRATAMENTO DA DOENCA DE PARKINSON
摘要 <p>By using a composition comprising rotigotine and at least one chloride salt in a concentration of 1 to 140 mmol/l, the composition having a pH of 4 to 6.5 in a iontophoretic device for the treatment of Parkinson's disease, it became possible to obtain a rotigotine flux across the human stratum corneum which was higher than the one previously obtained with conventional passive diffusion systems.</p>
申请公布号 PT1426049(E) 申请公布日期 2005.09.30
申请号 PT20020026871T 申请日期 2002.12.02
申请人 SCHWARZ PHARMA AG 发明人 JOHANNA AALTJE BOUWSTRA;HANS-MICHAEL WOLFF;GAI LING LI;AKHMAD KHARIS NUGROHO
分类号 A61K9/00;A61K31/381;A61K47/00;(IPC1-7):A61K31/381;A61P25/16 主分类号 A61K9/00
代理机构 代理人
主权项
地址